South Korea Multiomics Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Instruments and Consumables), By Type (Single-Cell and Bulk), By Platform (Genomics and Metabolomics), and South Korea Multiomics Market Insights, Industry Trend, Forecasts to 2035

South Korea Multiomics Market Insights Forecasts to 2035

• The South Korea Multiomics Market Size Was Estimated at USD 45.6 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 19.58% from 2025 to 2035
• The South Korea Multiomics Market Size is Expected to Reach USD 326.1 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The South Korea Multiomics Market Size is anticipated to Reach USD 326.1 Million by 2035, Growing at a CAGR of 19.58% from 2025 to 2035. The market's growth is mostly driven by the increasing need for single-cell multiomics and continuous improvements in omics technology.

Market Overview

The Multiomics Market Size combines data from several omics domains, including transcriptomics, proteomics, metabolomics, and genomics. By providing deeper insights into disease causes and patient-specific therapies, this method is transforming fields such as personalized medicine, drug discovery, and diagnostics, and strives to present a more comprehensive view of biological processes. New biomarkers for illness diagnosis and possible therapeutic targets can be found by using multiomics to uncover subtle patterns and relationships between many biological levels that may be overlooked when examining each layer alone. In clinical contexts, the application of multiomics for early disease identification, prognostic evaluation, and therapy selection is growing. Applications of multiomics are emerging in a variety of domains, including forensics, environmental studies, and agriculture. The GLHS Network and other government initiatives supporting genomics education and research are creating a pool of highly qualified experts in the subject.

Report Coverage

This research report categorizes the market for South Korea multiomics market based on various segments and regions forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea multiomics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea multiomics market.

Driving Factors

The rising demand for precision medicine, advancements in high-throughput sequencing technologies, and growing investments in biomedical research. Integration of genomics, proteomics, and metabolomics enables deeper insights into complex diseases, enhancing diagnostics and drug discovery. Increasing collaboration between research institutions and pharmaceutical companies further accelerates innovation.

Restraining Factors

The high infrastructure and operational costs needed for advanced instruments, reagents, and data analysis tools, making it inaccessible to smaller institutions. Regulatory and ethical hurdles, including privacy concerns, data-sharing barriers, and evolving guidelines, further delay adoption. The skills gap in bioinformatics and computational biology limits implementation, especially in resource-limited settings

Market Segmentation

The South Korea multiomics market share is classified into product & service, type, and platform.

• The instruments segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea multiomics market is segmented by product & service into instruments and consumables. Among these, the instruments segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The increasing adoption of advanced technologies for genomics, proteomics, and metabolomics research. Its growth is driven by rising R&D investments, demand for high-throughput analysis tools, and technological innovations enhancing data accuracy, speed, and integration capabilities.

• The single-cell segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea multiomics market is segmented by type into single-cell and bulk. Among these, the single-cell segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Their easy application, rapid action, and effectiveness in controlling bleeding in complex surgical procedures. Their growth is driven by rising demand for minimally invasive surgeries, enhanced surgical outcomes, and increasing adoption in hospitals and clinics.

• The genomics segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea multiomics market is segmented by platform into genomics and metabolomics. Among these, the genomics segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growing applications in personalized medicine, disease prediction, and drug development. Its strong growth is derived by government-funded genomic research, expanding biotech infrastructure, and increased demand for precision healthcare solutions leveraging next-generation sequencing and advanced bioinformatics tools.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea multiomics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Seegene Inc.
• grandviewresearch.com
• marketresearchfuture.com
• Park Systems Corp.
• SK Bioscience Co., Ltd.
• Green Cross Corporation (GC Biopharma)
• marketresearchfuture.com
• Lotte Biologics
• Samsung Biologics Co., Ltd.
• Macrogen
• genomics-apac.lifesciencesreviewapac.com
• Bio Design Lab
• Insilicogen, Inc.
• MDxK
• AhnLab
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea multiomics market based on the below-mentioned segments:

 South Korea Multiomics Market, By Product & Service

• Instruments
• Consumables

South Korea Multiomics Market, By Type

• Single-Cell
• Bulk

South Korea Multiomics Market, By Platform

• Genomics
• Metabolomics